128 related articles for article (PubMed ID: 21550076)
41. Miglitol, α-glycosidase inhibitor, reduces visceral fat accumulation and cardiovascular risk factors in subjects with the metabolic syndrome: a randomized comparable study.
Shimabukuro M; Higa M; Yamakawa K; Masuzaki H; Sata M
Int J Cardiol; 2013 Sep; 167(5):2108-13. PubMed ID: 22721642
[TBL] [Abstract][Full Text] [Related]
42. Comparing the efficacy of α-glucosidase inhibitors in suppressing postprandial hyperglycemia using continuous glucose monitoring: a pilot study-the MAJOR study.
Tsujino D; Nishimura R; Taki K; Morimoto A; Tajima N; Utsunomiya K
Diabetes Technol Ther; 2011 Mar; 13(3):303-8. PubMed ID: 21291335
[TBL] [Abstract][Full Text] [Related]
43. Miglitol (BAY m 1099) treatment of diabetic hypothalamic-dietary obese rats improves islet response to glucose.
Axen KV; Li X; Sclafani A
Obes Res; 1999 Jan; 7(1):83-9. PubMed ID: 10023734
[TBL] [Abstract][Full Text] [Related]
44. α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.
Shimabukuro M; Tanaka A; Sata M; Dai K; Shibata Y; Inoue Y; Ikenaga H; Kishimoto S; Ogasawara K; Takashima A; Niki T; Arasaki O; Oshiro K; Mori Y; Ishihara M; Node K;
Cardiovasc Diabetol; 2017 Jul; 16(1):86. PubMed ID: 28683829
[TBL] [Abstract][Full Text] [Related]
45. The herbal extract ALS-L1023 from Melissa officinalis reduces weight gain, elevated glucose levels and β-cell loss in Otsuka Long-Evans Tokushima fatty rats.
Shin Y; Lee D; Ahn J; Lee M; Shin SS; Yoon M
J Ethnopharmacol; 2021 Jan; 264():113360. PubMed ID: 32918993
[TBL] [Abstract][Full Text] [Related]
46. Hyperglycemia Enhances the Production of Amyloid β1-42 in the Lenses of Otsuka Long-Evans Tokushima Fatty Rats, a Model of Human Type 2 Diabetes.
Nagai N; Ito Y; Sasaki H
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1408-17. PubMed ID: 27028062
[TBL] [Abstract][Full Text] [Related]
47. d-allulose protects against diabetic nephropathy progression in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes.
Niibo M; Kanasaki A; Iida T; Ohnishi K; Ozaki T; Akimitsu K; Minamino T
PLoS One; 2022; 17(1):e0263300. PubMed ID: 35100325
[TBL] [Abstract][Full Text] [Related]
48. Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol.
Uzu T; Yokoyama H; Itoh H; Koya D; Nakagawa A; Nishizawa M; Maegawa H; Yokomaku Y; Araki S; Abiko A; Haneda M
Clin Exp Nephrol; 2011 Feb; 15(1):58-63. PubMed ID: 20824296
[TBL] [Abstract][Full Text] [Related]
49. Genome wide expression analysis of white blood cells and liver of pre-diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats using a cDNA microarray.
Iida S; Sato Y; Nakaya A; Shinohara Y; Hayashi Y; Sawada A; Nagata H; Kaji N; Kamiya H; Baba Y; Harashima H
Biol Pharm Bull; 2006 Dec; 29(12):2451-9. PubMed ID: 17142981
[TBL] [Abstract][Full Text] [Related]
50. Effect of 3-month repeated administration of miglitol on vascular endothelial function in patients with diabetes mellitus and coronary artery disease.
Emoto T; Sawada T; Hashimoto M; Kageyama H; Terashita D; Mizoguchi T; Mizuguchi T; Motodi Y; Iwasaki M; Taira K; Okamoto H; Matsuo Y; Kim SK; Takarada A; Yokoyama M
Am J Cardiol; 2012 Jan; 109(1):42-6. PubMed ID: 21944671
[TBL] [Abstract][Full Text] [Related]
51. Effect of miglitol administration to non-insulin-dependent diabetic rats.
Tormo MA; Ropero MF; Nieto M; Martinez IM; Campillo JE
Gen Pharmacol; 1998 Jan; 30(1):125-9. PubMed ID: 9457493
[TBL] [Abstract][Full Text] [Related]
52. Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099).
Russell JC; Graham SE; Dolphin PJ
Metabolism; 1999 Jun; 48(6):701-6. PubMed ID: 10381143
[TBL] [Abstract][Full Text] [Related]
53. Switching α-glucosidase inhibitors to miglitol reduced glucose fluctuations and circulating cardiovascular disease risk factors in type 2 diabetic Japanese patients.
Hariya N; Mochizuki K; Inoue S; Saito M; Fuchigami M; Goda T; Osonoi T
Drugs R D; 2014 Sep; 14(3):177-84. PubMed ID: 25079671
[TBL] [Abstract][Full Text] [Related]
54. Miglitol, a new alpha-glucosidase inhibitor.
Sels JP; Huijberts MS; Wolffenbuttel BH
Expert Opin Pharmacother; 1999 Nov; 1(1):149-56. PubMed ID: 11249557
[TBL] [Abstract][Full Text] [Related]
55. Miglitol prevents diet-induced obesity by stimulating brown adipose tissue and energy expenditure independent of preventing the digestion of carbohydrates.
Sasaki T; Shimpuku M; Kitazumi T; Hiraga H; Nakagawa Y; Shibata H; Okamatsu-Ogura Y; Kikuchi O; Kim HJ; Fujita Y; Maruyama J; Susanti VY; Yokota-Hashimoto H; Kobayashi M; Saito M; Kitamura T
Endocr J; 2013; 60(10):1117-29. PubMed ID: 23995917
[TBL] [Abstract][Full Text] [Related]
56. Improvement of insulin resistance, blood pressure and interstitial pH in early developmental stage of insulin resistance in OLETF rats by intake of propolis extracts.
Aoi W; Hosogi S; Niisato N; Yokoyama N; Hayata H; Miyazaki H; Kusuzaki K; Fukuda T; Fukui M; Nakamura N; Marunaka Y
Biochem Biophys Res Commun; 2013 Mar; 432(4):650-3. PubMed ID: 23416075
[TBL] [Abstract][Full Text] [Related]
57. Effect of the α-glucosidase inhibitor miglitol on the glucose profile in Japanese type 2 diabetic patients receiving multiple daily insulin injections.
Kato H; Ohta A; Kobayashi S; Ishii S; Sada Y; Kobayashi H; Ohmori S; Kondo A; Katabami T; Fuse J; Fukuda H; Nagai Y; Tanaka Y
Endocr J; 2012; 59(4):345-52. PubMed ID: 22301938
[TBL] [Abstract][Full Text] [Related]
58. [Usefulness of miglitol in patients with diabetes mellitus type 2 and insufficient control of the blood glucose].
de Luis Román DA; del Pozo García E; Aller R; Romero Bobillo E; Conde Valentín R
Rev Clin Esp; 2004 Jan; 204(1):32-4. PubMed ID: 14746760
[TBL] [Abstract][Full Text] [Related]
59. An α-glucosidase inhibitor could reduce T-wave alternans in type 2 diabetes patients.
Eguchi K; Komori T; Saito T; Hoshide S; Kario K
J Electrocardiol; 2018; 51(1):21-26. PubMed ID: 28918212
[TBL] [Abstract][Full Text] [Related]
60. Variation in gene expression of inflammatory cytokines in leukocyte-derived cells of high-fat-diet-induced insulin-resistant rats.
Fujimoto S; Mochizuki K; Shimada M; Murayama Y; Goda T
Biosci Biotechnol Biochem; 2008 Oct; 72(10):2572-9. PubMed ID: 18838815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
